{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T14:19:01Z","timestamp":1777126741387,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ejog.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ejogrb.2017.09.020","type":"journal-article","created":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T01:31:43Z","timestamp":1506562303000},"page":"129-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Efficacy of 5% imiquimod for the treatment of Vaginal intraepithelial neoplasia\u2014A systematic review of the literature and a meta-analysis"],"prefix":"10.1016","volume":"218","author":[{"given":"A.","family":"Tranoulis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Laios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Mitsopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Lutchman-Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Thomakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejogrb.2017.09.020_bib0005","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0002-9378(77)90091-6","article-title":"An epidemiologic study of cancer of the cervix, vagina, and vulva based on the Third National Cancer Survey in the United States","volume":"129","author":"Henson","year":"1977","journal-title":"Am J Obstet Gynecol"},{"issue":"April (7)","key":"10.1016\/j.ejogrb.2017.09.020_bib0010","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/ijc.24116","article-title":"Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis","volume":"124","author":"De Vuyst","year":"2009","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2017.09.020_bib0015","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/gyno.2001.6401","article-title":"Clinical features and risk of recurrence among patients with vaginal intraepithelial neoplasia","volume":"83","author":"Dodge","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2017.09.020_bib0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0301-2115(02)00209-9","article-title":"Vaginal intraepithelial neoplasia: treatment by carbon dioxide laser and risk factors for failure","volume":"106","author":"Yalcin","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"10.1016\/j.ejogrb.2017.09.020_bib0025","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ajog.2005.03.055","article-title":"Upper vaginectomy for the treatment of vaginal intraepithelial neoplasia","volume":"193","author":"Indermaur","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2017.09.020_bib0030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/1097-0142(19910701)68:1<195::AID-CNCR2820680135>3.0.CO;2-L","article-title":"Natural history of vaginal intraepithelial neoplasia","volume":"68","author":"Aho","year":"1991","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejogrb.2017.09.020_bib0035","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1447-0756.2009.01108.x","article-title":"Vaginal intraepithelial neoplasia: a retrospective analysis of clinical features and colpohistology","volume":"36","author":"Boonlikit","year":"2010","journal-title":"J Obstet Gynaecol Res"},{"issue":"5","key":"10.1016\/j.ejogrb.2017.09.020_bib0040","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ajog.2013.01.047","article-title":"A contemporary analysis of epidemiology and management of vaginal intraepithelial neoplasia","volume":"208","author":"Gunderson","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2017.09.020_bib0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/LGT.0b013e31829f52f4","article-title":"Vaginal intraepithelial neoplasia (VaIN 2\/3): comparing clinical outcomes of treatment with intravaginal estrogen","volume":"18","author":"Rhodes","year":"2014","journal-title":"J Low Genit Tract Dis"},{"issue":"3","key":"10.1016\/j.ejogrb.2017.09.020_bib0050","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ygyno.2016.03.033","article-title":"Recurrence and risk of progression to lower genital tract malignancy in women with high grade VAIN","volume":"141","author":"Hodeib","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2017.09.020_bib0055","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.1158\/1078-0432.CCR-12-1149","article-title":"Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer","volume":"18","author":"Adams","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejogrb.2017.09.020_bib0060","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni758","article-title":"Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway","volume":"3","author":"Hemmi","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ejogrb.2017.09.020_bib0065","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methological index for non-randomised studies (minors): development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.ejogrb.2017.09.020_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"issue":"5","key":"10.1016\/j.ejogrb.2017.09.020_bib0075","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJM200208013470521","article-title":"Treatment of high-grade vaginal intraepithelial neoplasia with imiquimod cream","volume":"347","author":"Diakomanolis","year":"2002","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ejogrb.2017.09.020_bib0080","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/00128360-200310000-00011","article-title":"Treatment of vaginal intraepithelial neoplasia (primarily low grade) with imiquimod 5% cream","volume":"7","author":"Buck","year":"2003","journal-title":"J Low Genit Tract Dis"},{"issue":"5","key":"10.1016\/j.ejogrb.2017.09.020_bib0085","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1525-1438.2005.00152.x","article-title":"Can local application of imiquimod cream be an alternative mode of therapy for patients with high-grade intraepithelial lesions of the vagina?","volume":"15","author":"Haidopoulos","year":"2005","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.ejogrb.2017.09.020_bib0090","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.tjog.2013.10.004","article-title":"Efficacy of imiquimod 5% cream for persistent human papillomavirus in genital intraepithelial neoplasm","volume":"52","author":"Chen","year":"2013","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2017.09.020_bib0095","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1097\/LGT.0000000000000214","article-title":"Topical therapy with imiquimod for vaginal intraepithelial neoplasia: a case series","volume":"20","author":"Policiano","year":"2016","journal-title":"J Low Genit Tract Dis"},{"issue":"10","key":"10.1016\/j.ejogrb.2017.09.020_bib0100","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1002\/ijc.30275","article-title":"Randomised trial on treatment of vaginal intraepithelial neoplasia-Imiquimod, laser vaporisation and expectant management","volume":"139","author":"Tainio","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejogrb.2017.09.020_bib0105","first-page":"457","article-title":"Vaginal intraepithelial neoplasia: report of 102 cases","volume":"23","author":"Diakomanolis","year":"2002","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.ejogrb.2017.09.020_bib0110","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0301-2115(02)00209-9","article-title":"Vaginal intraepithelial neoplasia: treatment by carbon dioxide laser and risk factors for failure","volume":"106","author":"Omer","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2017.09.020_bib0115","first-page":"90","article-title":"Treatment of vaginal intraepithelial neoplasia with the carbon dioxide laser","volume":"62","author":"Jobson","year":"1983","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2017.09.020_bib0120","first-page":"657","article-title":"Treatment of vaginal intraepithelial neoplasia with laser and topical 5-fluorouracil","volume":"73","author":"Krebs","year":"1989","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2017.09.020_bib0125","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00404-005-0022-1","article-title":"Vaginal intraepithelial neoplasia: clinical- therapeutic analysis of 33 cases","volume":"272","author":"Murta","year":"2005","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2017.09.020_bib0130","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00006250-198003000-00016","article-title":"Treatment of vaginal dysplasia and carcinoma in situ with topical 5-fluorouracil","volume":"55","author":"Daly","year":"1980","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ejogrb.2017.09.020_bib0135","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.tjog.2012.09.006","article-title":"Topical imiquimod treatment for human papillomavirus infection in patients with and without cervical\/vaginal intraepithelial neoplasia","volume":"51","author":"Lin","year":"2012","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ejogrb.2017.09.020_bib0140","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.0906-6705.2006.00414.x","article-title":"Immune response modifiers-mode of action","volume":"15","author":"Schiller","year":"2006","journal-title":"Exp Dermatol"},{"issue":"2","key":"10.1016\/j.ejogrb.2017.09.020_bib0145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2133.2007.08265.x","article-title":"Imiquimod: mode of action","volume":"157","author":"Sch\u00f6n","year":"2007","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.ejogrb.2017.09.020_bib0150","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1002\/ijc.25302","article-title":"Imiquimod-induced clearance of HPV is associated with normalization of immune cell counts in usual type vulvar intraepithelial neoplasia","volume":"127","author":"Terlou","year":"2010","journal-title":"Int J Cancer"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211517304554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211517304554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T03:35:24Z","timestamp":1535340924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211517304554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":30,"alternative-id":["S0301211517304554"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2017.09.020","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of 5% imiquimod for the treatment of Vaginal intraepithelial neoplasia\u2014A systematic review of the literature and a meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2017.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2017 Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}